| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1127687911 |
| P356 | DOI | 10.1101/2020.05.12.091256 |
| P932 | PMC publication ID | 7263489 |
| P698 | PubMed publication ID | 32511361 |
| P8299 | Semantic Scholar corpus ID | 218764868 |
| P50 | author | Yao Shen | Q89613349 |
| Charles Karan | Q90243414 | ||
| Pasquale Laise | Q95603135 | ||
| Xiaoyun Sun | Q95603138 | ||
| Sergey Pampou | Q95603140 | ||
| Andrea Califano | Q29053203 | ||
| Ronald Realubit | Q56986906 | ||
| Mariano J Alvarez | Q60619644 | ||
| Eugene F Douglass | Q81031546 | ||
| P2093 | author name string | Yao Shen | |
| Mariano J Alvarez | |||
| Xiaoyun Sun | |||
| Gideon Bosker | |||
| Sergey Pampou | |||
| Charles Karan | |||
| Pasquale Laise | |||
| Eugene F Douglass | |||
| Ronald B Realubit | |||
| P2860 | cites work | A Novel Coronavirus from Patients with Pneumonia in China, 2019 | Q86729469 |
| Therapeutic options for the 2019 novel coronavirus (2019-nCoV) | Q88045822 | ||
| Everolimus delayed and suppressed cytomegalovirus DNA synthesis, spread of the infection, and alleviated cytomegalovirus infection | Q90450213 | ||
| Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2 | Q90482543 | ||
| Modulation of the unfolded protein response pathway as an antiviral approach in airway epithelial cells | Q90502942 | ||
| Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review | Q91855760 | ||
| Oral Selinexor-Dexamethasone for Triple-Class Refractory Multiple Myeloma | Q92750771 | ||
| A SARS-CoV-2 protein interaction map reveals targets for drug repurposing | Q94470555 | ||
| Cellular roles of dna topoisomerases: a molecular perspective | Q22121990 | ||
| A human B-cell interactome identifies MYB and FOXM1 as master regulators of proliferation in germinal centers | Q24318306 | ||
| Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles | Q24536351 | ||
| FDA-approved selective estrogen receptor modulators inhibit Ebola virus infection. | Q24568225 | ||
| Adapting the Stress Response: Viral Subversion of the mTOR Signaling Pathway | Q26700049 | ||
| Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen | Q26747306 | ||
| Induction and function of type I and III interferon in response to viral infection | Q27010065 | ||
| Interrogation of a context-specific transcription factor network identifies novel regulators of pluripotency | Q27329779 | ||
| Flavivirus Activates Phosphatidylinositol 3-Kinase Signaling To Block Caspase-Dependent Apoptotic Cell Death at the Early Stage of Virus Infection | Q27469840 | ||
| Linear models and empirical bayes methods for assessing differential expression in microarray experiments | Q27860758 | ||
| Control of cell cycle transcription during G1 and S phases | Q28295030 | ||
| Mammalian G1- and S-phase checkpoints in response to DNA damage | Q29013238 | ||
| Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 | Q29547403 | ||
| STAR: ultrafast universal RNA-seq aligner | Q29615052 | ||
| Reverse engineering of regulatory networks in human B cells | Q30004211 | ||
| New drug-strategies to tackle viral-host interactions for the treatment of influenza virus infections | Q30234387 | ||
| The SARS-coronavirus papain-like protease: structure, function and inhibition by designed antiviral compounds. | Q30370367 | ||
| Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection | Q30419612 | ||
| A network integration approach to predict conserved regulators related to pathogenicity of influenza and SARS-CoV respiratory viruses | Q31126174 | ||
| Dynamic innate immune responses of human bronchial epithelial cells to severe acute respiratory syndrome-associated coronavirus infection | Q33525586 | ||
| The transcriptional network for mesenchymal transformation of brain tumours. | Q33572162 | ||
| Hepatitis C virus NS5A activates the mammalian target of rapamycin (mTOR) pathway, contributing to cell survival by disrupting the interaction between FK506-binding protein 38 (FKBP38) and mTOR | Q33966987 | ||
| Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture | Q34058365 | ||
| The SARS-coronavirus-host interactome: identification of cyclophilins as target for pan-coronavirus inhibitors | Q34064211 | ||
| Antiviral drugs specific for coronaviruses in preclinical development | Q34332580 | ||
| Antiviral potential of ERK/MAPK and PI3K/AKT/mTOR signaling modulation for Middle East respiratory syndrome coronavirus infection as identified by temporal kinome analysis | Q34452682 | ||
| Protease inhibitors targeting coronavirus and filovirus entry | Q34461982 | ||
| The Molecular Signatures Database (MSigDB) hallmark gene set collection | Q34509167 | ||
| Coronaviruses - drug discovery and therapeutic options. | Q34513643 | ||
| Identifying candidate drivers of alcohol dependence-induced excessive drinking by assembly and interrogation of brain-specific regulatory networks | Q35540682 | ||
| The severe acute respiratory syndrome | Q35610030 | ||
| AP-2-associated protein kinase 1 and cyclin G-associated kinase regulate hepatitis C virus entry and are potential drug targets | Q35641039 | ||
| Identification of neurodegenerative factors using translatome-regulatory network analysis | Q35716130 | ||
| Cyclopiazonic acid, an inhibitor of calcium-dependent ATPases with antiviral activity against human respiratory syncytial virus | Q36025756 | ||
| The Regulatory Machinery of Neurodegeneration in In Vitro Models of Amyotrophic Lateral Sclerosis | Q36284525 | ||
| Functional characterization of somatic mutations in cancer using network-based inference of protein activity | Q37292348 | ||
| Anticancer kinase inhibitors impair intracellular viral trafficking and exert broad-spectrum antiviral effects | Q37730661 | ||
| PLATE-Seq for genome-wide regulatory network analysis of high-throughput screens | Q38663616 | ||
| Host Factors in Coronavirus Replication | Q38667715 | ||
| Free fatty acids or high-concentration glucose enhances hepatitis A virus replication in association with a reduction in glucose-regulated protein 78 expression | Q38725811 | ||
| Elucidation and Pharmacological Targeting of Novel Molecular Drivers of Follicular Lymphoma Progression | Q38817982 | ||
| Differential Phosphatidylinositol-3-Kinase-Akt-mTOR Activation by Semliki Forest and Chikungunya Viruses Is Dependent on nsP3 and Connected to Replication Complex Internalization. | Q38838063 | ||
| Dasatinib inhibits HIV-1 replication through the interference of SAMHD1 phosphorylation in CD4+ T cells | Q38911430 | ||
| West nile virus-induced activation of mammalian target of rapamycin complex 1 supports viral growth and viral protein expression | Q38985660 | ||
| Cross-species regulatory network analysis identifies a synergistic interaction between FOXM1 and CENPF that drives prostate cancer malignancy | Q38995507 | ||
| Chikungunya virus nsP3 & nsP4 interacts with HSP-90 to promote virus replication: HSP-90 inhibitors reduce CHIKV infection and inflammation in vivo. | Q39037522 | ||
| The recurrent architecture of tumour initiation, progression and drug sensitivity | Q39039006 | ||
| Anti-herpes simplex virus efficacies of 2-aminobenzamide derivatives as novel HSP90 inhibitors. | Q39330301 | ||
| The coronavirus endoribonuclease Nsp15 interacts with retinoblastoma tumor suppressor protein | Q39402493 | ||
| Use of Everolimus-based Immunosuppression to Decrease Cytomegalovirus Infection After Kidney Transplant | Q39866818 | ||
| Effect of the phosphatidylinositol 3-kinase/Akt pathway on influenza A virus propagation | Q40166064 | ||
| The nucleocapsid protein of severe acute respiratory syndrome-coronavirus inhibits the activity of cyclin-cyclin-dependent kinase complex and blocks S phase progression in mammalian cells | Q40326049 | ||
| Respiratory syncytial virus induces phosphorylation of mTOR at ser2448 in CD8 T cells from nasal washes of infected infants. | Q40465877 | ||
| Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2. | Q42844863 | ||
| Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States | Q45118572 | ||
| The Cellular Chaperone Heat Shock Protein 90 Is Required for Foot-and-Mouth Disease Virus Capsid Precursor Processing and Assembly of Capsid Pentamers | Q45323695 | ||
| An Integrated Systems Biology Approach Identifies TRIM25 as a Key Determinant of Breast Cancer Metastasis. | Q47945450 | ||
| Lung pathology of fatal severe acute respiratory syndrome. | Q51670647 | ||
| Quantitative assessment of protein activity in orphan tissues and single cells using the metaVIPER algorithm. | Q52584634 | ||
| Cross-Cohort Analysis Identifies a TEAD4-MYCN Positive Feedback Loop as the Core Regulatory Element of High-Risk Neuroblastoma. | Q52671240 | ||
| Feasibility and biological rationale of repurposing sunitinib and erlotinib for dengue treatment. | Q54110307 | ||
| The impact of a negligent G2/M checkpoint on genomic instability and cancer induction. | Q55044969 | ||
| A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumors | Q56967089 | ||
| Neuraminidase inhibitor resistance in influenza: a clinical perspective | Q57296842 | ||
| The clinically approved MEK inhibitor Trametinib efficiently blocks influenza A virus propagation and cytokine expression | Q58180341 | ||
| Medium throughput breathing human primary cell alveolus-on-chip model | Q58698648 | ||
| Identification of critical determinants on ACE2 for SARS-CoV entry and development of a potent entry inhibitor | Q82697155 | ||
| Human Coronavirus: Host-Pathogen Interaction | Q84315459 | ||
| P577 | publication date | 2020-05-18 | |
| P1476 | title | The Host Cell ViroCheckpoint: Identification and Pharmacologic Targeting of Novel Mechanistic Determinants of Coronavirus-Mediated Hijacked Cell States |
Search more.